6-K 1 zk2126753.htm 6-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2021
Commission File No.: 000-30668
 
NOVA LTD.
(Translation of registrant’s name into English)

5 David Fikes Street, Rehovot, Israel
 (Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 

Form 20-F ☒     Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ 
 
Attached hereto and incorporated by way of reference herein is a press release issued by the Registrant and entitled: “Nova Reports Record Third Quarter 2021 Results”.

The GAAP financial statements tables included in the press release attached hereto are hereby incorporated by reference into the Registrant’s registration statements on Form S-8, filed with the Securities and Exchange Commission on the following dates: November 5, 2007 (File No. 333-147140); October 25, 2012 (File No. 333-184585), March 6, 2015 (File No. 333-202550); and August 25, 2017 (File No. 333-220158).


 
SIGNATURES

 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

Date: November 4, 2021

 
NOVA LTD.
(Registrant)

By: /s/ Dror David
Dror David
Chief Financial Officer




Company Contact:
Dror David, Chief Financial Officer
Tel: +972-73-229-5760
Nova website link - https://www.novami.com/
 
Investor Relations Contact:
Miri Segal MS-IR LLC
Tel: +917-607-8654
 
Nova Reports Record Third Quarter 2021 Results

Rehovot, Israel, November 4, 2021 - Nova (Nasdaq: NVMI) today announced record financial results for the third quarter of 2021, the period ended September 30, 2021.
 
Third Quarter 2021 Highlights:
 

Record quarterly revenue of $112.7 million, up 62% year over year
 

Record GAAP net income of $30.3 million, or $1.02 per diluted share, up 113% year over year
on a per-share basis
 

Record non-GAAP net income of $34.5 million, or $1.16 per diluted share, up 104% year over year
on a per-share basis
 

Record materials metrology revenue driven by expanded product portfolio and new logic penetration
 

Continuous adoption of the NovaPRISM® standalone platform across segments and customers
 
GAAP Results ($K)

 
Q3 2021
Q2 2021
Q3 2020
Revenues
$112,713
$97,746
$69,485
Net Income
$30,335
$22,924
$13,869
Earnings per Diluted Share
$1.02
$0.77
$0.48
 
NON-GAAP Results ($K)

 
Q3 2021
Q2 2021
Q3 2020
Net Income
$34,546
$26,886
$16,511
Earnings per Diluted Share
$1.16
$0.90
$0.57
 
A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are part of this release. See also "Use of Non-GAAP Adjusted Financial Measures" section.
 
Management Comments
 
"We remain confident in our strategy and the long-term value we create for our customers as they move towards production of next-generation devices across all technologies and segments. With the global surge in demand and the commensurate challenges to production capacity, our technology value continues to resonate strongly with a wide range of customers. This was demonstrated in the third quarter by several  selection wins and by the successful proliferation of our industry-leading technologies," commented Eitan Oppenhaim, President and Chief Executive Officer. "The increasing demand for our innovative portfolio along with the current market demand, paves us the way to another outperformance year in 2021 and builds a solid momentum towards 2022."
 


2021 Fourth Quarter Financial Outlook
 
Management provided an outlook for the fourth quarter, the period ending December 31, 2021. Based on current estimates, management expects:
 

$113 million to $123 million in revenue
 

$0.78 to $0.96 in diluted GAAP EPS
 

$0.94 to $1.12 in diluted non-GAAP EPS

2021 Third Quarter Results
 
Total revenues for the third quarter of 2021 were $112.7 million, an increase of 15% compared with the second quarter of 2021 and an increase of 62% compared with the third quarter of 2020.
 
Gross margin in the third quarter of 2021 was 58%, compared with 57% in the second quarter of 2021 and 57% in the third quarter of 2020.
 
Operating expenses in the third quarter of 2021 were $29.7 million, compared with $28.7 million in the second quarter of 2021 and $24.1 million in the third quarter of 2020.
 
On a GAAP basis, the Company reported net income of $30.3 million, or $1.02 per diluted share, in the third quarter of 2021. This is compared with net income of $22.9 million, or $0.77 per diluted share, in the second quarter of 2021, and net income of $13.9 million, or $0.48 per diluted share, in the third quarter of 2020.
 
On a non-GAAP basis, the Company reported net income of $34.5 million, or $1.16 per diluted share, in the third quarter of 2021. This is compared with net income of $26.9 million, or $0.90 per diluted share, in the second quarter of 2021, and net income of $16.5 million, or $0.57 per diluted share, in the third quarter of 2020.

Conference Call Information
 
Nova will host a conference call today, November 4, 2021, at 8:30 a.m. Eastern Time, to discuss the financial results and outlook. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

U.S. TOLL-FREE Dial-in Number: 1-855-327-6837
ISRAEL TOLL-FREE Dial-in Number: 1-809-458-327
INTERNATIONAL Dial-in Number: 1-631-891-4304

At:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
2:30 p.m. Israel Time
Please reference conference ID: 10016821
 
The conference call will also be webcast live from a link on (https://viavid.webcasts.com/starthere.jsp?ei=1503947&tp_key=bf95aab94b)

A replay of the conference call will be available from November 4, 2021 at 11:30 a.m. Eastern Time to November 11, 2021 at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers:
 
Replay Dial-in TOLL-FREE: 1-844-512-2921
Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-6671
Replay Pin Number: 10016821


A replay will also be available for 90 days on Nova's website at https://www.novami.com/investors/events/.



 
About Nova
 
Nova is a leading innovator and key provider of metrology solutions for advanced process control used in semiconductor manufacturing. Nova delivers continuous innovation by providing state-of-the-art high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova's product portfolio, which combines high-precision hardware and cutting-edge software, provides its customers with deep insight into the development and production of the most advanced semiconductor devices. Nova's unique capability to deliver innovative X-ray and optical solutions enables its customers to improve performance, enhance product yields and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices around the world. Additional information may be found at Nova website link - https://www.novami.com/.
 
Nova is traded on the Nasdaq & TASE, Nasdaq ticker symbol NVMI.
 
Use of Non-GAAP Adjusted Financial Measures
 
This press release provides financial measures that exclude amortization of acquired intangible assets, stock-based compensation expenses, revaluation of operating lease liabilities, amortization of debt discount and issuance costs and tax effect of non-GAAP adjustment, as applicable, and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding Nova's performance because they reflect our operational results and enhance management's and investors' ability to evaluate Nova's performance before charges or benefits considered by management to be outside Nova's ongoing operating results. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management believes that it is in the best interest of its investors to provide financial information that will facilitate comparison of both historical and future results and allow greater transparency to supplemental information used by management in its financial and operational decision making. A reconciliation of each GAAP to non-GAAP financial measure discussed in this press release is contained in the accompanying financial tables.
 
Forward-Looking Statements
 
This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in those forward-looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: catastrophic events such as the outbreak of COVID-19; increased information technology security threats and sophisticated computer crime; foreign political and economic risks; changes in U.S. trade policies; inability to protect intellectual property; open source technology exposure; failure to compete effectively or to respond to the rapid technological changes; consolidation in our industry; difficulty to predict the length and strength of any downturn or expansion period of the market we target; factors that adversely affect the pricing and demand for our product lines; dependency on a small number of large customers; dependency on a single manufacturing facility per product line; dependency on a limited number of suppliers; lengthy sales cycle and customer delays in orders; political, economic, and military instability in Israel; risks related to our convertible notes; currency fluctuations; and quarterly fluctuations in our operating results. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading "Risk Factors" in Nova's Annual Report on Form 20-F for the year ended December 31, 2020 filed with the Securities and Exchange Commission on March 1, 2021. These factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Ltd. does not assume any obligation to update the forward-looking information contained in this press release.

(Tables to Follow)



 
NOVA LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands) - (Unaudited)

   
As of
 
ASSETS
 
September 30,
2021
   
December 31,
2020
 
Current assets
           
Cash and cash equivalents
   
72,127
     
232,304
 
Short-term interest-bearing bank deposits
   
258,970
     
191,567
 
Marketable securities
   
78,889
     
-
 
Trade accounts receivable, net
   
64,630
     
63,314
 
Inventories
   
73,390
     
61,734
 
Other current assets
   
10,056
     
9,782
 
Total current assets
   
558,062
     
558,701
 
Non-current assets
               
Marketable securities
   
120,940
     
-
 
Interest-bearing bank deposits
   
3,536
     
2,547
 
Restricted interest-bearing bank deposits
   
1,750
     
1,476
 
Deferred tax assets
   
5,117
     
2,869
 
Other long-term assets
   
571
     
462
 
Severance pay funds
   
1,253
     
1,281
 
Operating lease right-of-use assets
   
28,570
     
29,109
 
Property and equipment, net
   
32,791
     
34,168
 
Intangible assets, net
   
3,336
     
5,059
 
Goodwill
   
20,114
     
20,114
 
Total non-current assets
   
217,978
     
97,085
 
Total assets
   
776,040
     
655,786
 
 LIABILITIES AND SHAREHOLDERS' EQUITY
               
Current liabilities
               
Convertible senior notes, net
   
181,962
     
-
 
Trade accounts payable
   
29,008
     
24,096
 
Deferred revenues
   
31,910
     
4,717
 
Operating lease current liabilities
   
4,153
     
3,703
 
Other current liabilities
   
35,754
     
28,418
 
Total current liabilities
   
282,787
     
60,934
 
Non-current liabilities
               
Convertible senior notes, net
   
-
     
178,808
 
Accrued severance pay
   
3,745
     
3,719
 
Operating lease long-term liabilities
   
31,039
     
31,905
 
Other long-term liability
   
9,923
     
8,882
 
Total non-current liabilities
   
44,707
     
223,314
 
Shareholders' equity
   
448,546
     
371,538
 
Total liabilities and shareholders' equity
   
776,040
     
655,786
 


 
NOVA LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 (U.S. dollars in thousands, except per share data) - (Unaudited)

   
Three months ended September 30,
   
Nine months ended September 30,
 
   
2021
   
2020
   
2021
   
2020
 
Revenues:
                       
Products
   
92,552
     
54,757
     
237,128
     
147,579
 
Services
   
20,161
     
14,728
     
57,464
     
45,514
 
Total revenues
   
112,713
     
69,485
     
294,592
     
193,093
 
Cost of revenues
   
47,475
     
29,828
     
125,480
     
82,493
 
Gross profit
   
65,238
     
39,657
     
169,112
     
110,600
 
Operating expenses:
                               
Research and development, net
   
15,858
     
12,957
     
45,717
     
37,262
 
Sales and marketing
   
9,145
     
7,406
     
28,117
     
21,232
 
General and administrative
   
4,135
     
3,141
     
11,062
     
11,505
 
Amortization of acquired intangible assets
   
574
     
625
     
1,723
     
1,877
 
Total operating expenses
   
29,712
     
24,129
     
86,619
     
71,876
 
Operating income
   
35,526
     
15,528
     
82,493
     
38,724
 
Financing income (expense), net
   
(889
)
   
846
     
(1,615
)
   
2,261
 
Income before tax on income
   
34,637
     
16,374
     
80,878
     
40,985
 
Income tax expenses
   
4,302
     
2,478
     
10,003
     
6,735
 
Net income for the period
   
30,335
     
13,896
     
70,875
     
34,250
 
                                 
Earnings per share:
                               
Basic
   
1.07
     
0.49
     
2.50
     
1.22
 
Diluted
   
1.02
     
0.48
     
2.39
     
1.18
 
                                 
Shares used for calculation of earnings per share (in thousands):
                               
Basic
   
28,429
     
28,168
     
28,316
     
28,080
 
Diluted
   
29,858
     
29,020
     
29,660
     
28,933
 


 
NOVA LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S. dollars in thousands) - (Unaudited)

   
Three months ended September 30,
   
Nine months ended September e 30,
 
   
2021
   
2020
   
2021
   
2020
 
Cash flows from operating activities:
                       
Net income
 
$
30,335
   
$
13,896
   
$
70,875
   
$
34,250
 
Adjustments to reconcile net income to net cash provided by operating activities:
                               
Depreciation of property and equipment
   
1,619
     
1,474
     
4,794
     
4,303
 
Amortization of intangible assets
   
574
     
625
     
1,723
     
1,877
 
Amortization of premium and accretion of discount on marketable securities, net
   
570
      -
     
853
      -
 
Amortization of debt discount and issuance costs
   
1,069
     
-
     
3,154
     
-
 
Share-based compensation
   
2,642
     
1,946
     
6,992
     
4,718
 
Net effect of exchange rate fluctuation
   
(63
)
   
(618
)
   
(51
)
   
(397
)
Changes in assets and liabilities:
                               
Trade accounts receivables, net
   
(6,423
)
   
3,360
     
(1,316
)
   
10,506
 
Inventories
   
(2,245
)
   
(6,582
)
   
(12,493
)
   
(15,052
)
Other current and long-term assets
   
(276
)
   
484
     
(884
)
   
5,223
 
Deferred tax assets, net
   
(534
)
   
(182
)
   
(2,248
)
   
(728
)
Operating lease right-of-use assets
   
374
     
352
     
1,191
     
956
 
Trade accounts payables
   
2,527
     
1,362
     
4,898
     
2,027
 
Deferred revenues
   
18,319
     
2,626
     
27,193
     
1,535
 
Operating lease liabilities
   
117
     
(865
)
   
(1,068
)
   
(1,255
)
Other current and long-term liabilities
   
4,027
     
3,050
     
8,332
     
5,622
 
Accrued severance pay, net
   
(1
)
   
42
     
54
     
192
 
Net cash provided by operating activities
   
52,631
     
20,970
     
111,999
     
53,777
 
Cash flows from investment activities:
                               
Change in short-term and long-term interest-bearing bank deposits
   
(15,335
)
   
(13,139
)
   
(68,679
)
   
(46,141
)
Investment in marketable securities
   
(107,261
)
   
-
     
(208,727
)
   
-
 
Proceed from sales and maturities of marketable securities
   
6,521
     
-
     
7,721
     
-
 
Purchase of property and equipment
   
(760
)
   
(1,713
)
   
(2,566
)
   
(4,873
)
Net cash used in investing activities
   
(116,835
)
   
(14,852
)
   
(272,251
)
   
(51,014
)
Cash flows from financing activities:
                               
Purchases of treasury shares
   
-
     
-
     
-
     
(2,549
)
Proceeds from exercise of options
   
11
     
114
     
11
     
367
 
Net cash used in financing activities
   
11
     
114
     
11
     
(2,182
)
Effect of exchange rate fluctuations on cash and cash equivalents
   
30
     
596
     
64
     
384
 
Decrease in cash and cash equivalents
   
(64,163
)
   
6,828
     
(160,177
)
   
965
 
Cash and cash equivalents - beginning of period
   
136,290
     
25,885
     
232,304
     
31,748
 
Cash and cash equivalents - end of period
 
$
72,127
   
$
32,713
   
$
72,127
   
$
32,713
 
 

NOVA LTD.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(U.S. dollars in thousands, except percentage and per share data) - (Unaudited)

   
Three months ended
 
   
September 30,
2021
   
June 30,
2021
   
September 30,
2020
 
GAAP gross profit
   
65,238
     
55,944
     
39,657
 
Stock-based compensation expenses *
   
557
     
382
     
414
 
Non-GAAP gross profit
   
65,795
     
56,326
     
40,071
 
GAAP gross margin as a percentage of revenues
   
58
%
   
57
%
   
57
%
Non-GAAP gross margin as a percentage of revenues
   
58
%
   
58
%
   
58
%
                         
GAAP operating income
   
35,526
     
27,209
     
15,528
 
Stock-based compensation expenses *
   
2,642
     
2,128
     
1,946
 
Amortization of acquired intangible assets
   
574
     
574
     
625
 
Non-GAAP operating income
   
38,742
     
29,911
     
18,099
 
GAAP operating margin as a percentage of revenues
   
32
%
   
28
%
   
22
%
Non-GAAP operating margin as a percentage of revenues
   
34
%
   
31
%
   
26
%
                         
GAAP net income
   
30,335
     
22,924
     
13,896
 
Stock-based compensation expenses *
   
2,642
     
2,128
     
1,946
 
Amortization of acquired intangible assets
   
574
     
574
     
625
 
Amortization of debt discount and issuance costs
   
1,069
     
1,051
     
-
 
Revaluation of operating lease liabilities
   
217
     
554
     
161
 
Tax effect of non-GAAP adjustments
   
(291
)
   
(345
)
   
(117
)
Non-GAAP net income
   
34,546
     
26,886
     
16,511
 
                         
GAAP basic earnings per share
   
1.07
     
0.81
     
0.49
 
Non-GAAP basic earnings per share
   
1.22
     
0.95
     
0.59
 
                         
GAAP diluted earnings per share
   
1.02
     
0.77
     
0.48
 
Non-GAAP diluted earnings per share
   
1.16
     
0.90
     
0.57
 
                         
Shares used for calculation of earnings per share (in thousands):
                       
Basic
   
28,429
     
28,304
     
28,168
 
Diluted
   
29,858
     
29,815
     
29,020
 

* Stock-based compensation expenses for the three months ended September 30, 2021 included in – Cost of revenues - 557; Research and development expenses, net – 1,025; Sales and marketing expenses – 476; General and administrative expenses – 584


 
NOVA LTD.
SUPPLEMENTAL INFORMATION - RECONCILIATION OF FOURTH QUARTER 2021
GAAP TO NON-GAAP GUIDANCE
(Unaudited)

   
Low
   
High
 
Estimated GAAP net income per diluted share
   
0.78
     
0.96
 
Estimated non-GAAP items:
               
Stock-based compensation expenses
   
0.11
     
0.11
 
Amortization of acquired intangible assets
   
0.02
     
0.02
 
Amortization of debt discount and issuance costs
   
0.04
     
0.04
 
Tax effect of non-GAAP adjustments
   
(0.01
)
   
(0.01
)
Estimated non-GAAP net income per diluted share
   
0.94
     
1.12